Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Preventive effects of lemborexant on postoperative delirium in patients with proximal femur fracture surgery and insomnia in the perioperative period: a double-blind, randomized, non-inferiority trial of lemborexant versus ramelteon

Next Previous
Trial Profile

Preventive effects of lemborexant on postoperative delirium in patients with proximal femur fracture surgery and insomnia in the perioperative period: a double-blind, randomized, non-inferiority trial of lemborexant versus ramelteon

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Apr 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lemborexant (Primary) ; Ramelteon (Primary)
  • Indications Insomnia; Postoperative complications
  • Focus Therapeutic Use

Most Recent Events

  • 04 Apr 2022 Planned End Date changed from 31 Mar 2022 to 31 Mar 2023.
  • 13 Oct 2020 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top